Stoke Therapeutics (NASDAQ:STOK) Shares Down 4%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price dropped 4% during mid-day trading on Tuesday . The stock traded as low as $13.75 and last traded at $13.83. Approximately 166,733 shares traded hands during trading, a decline of 82% from the average daily volume of 922,683 shares. The stock had previously closed at […]

Related Keywords

Florida ,United States ,Jonathan Allan ,Cantor Fitzgerald ,Stoke Therapeutics Inc ,Dorsey Whitney Trust ,Canaccord Genuity Group ,Nasdaq ,York Mellon Corp ,Jpmorgan Chase Co ,Securities Exchange Commission ,Needham Company ,Pricet Rowe Associates Inc ,Board Of Administration Florida Retirement System ,Stoke Therapeutics Company Profile ,Stoke Therapeutics ,Get Free Report ,Genuity Group ,Exchange Commission ,General Counsel Jonathan Allan ,New York Mellon Corp ,Financial Markets ,Florida Retirement System ,Whitney Trust ,Stoke Therapeutics Daily ,